PEStore

Buyout PE

LongueVue Capital

LongueVue Capital acquires controlling stakes in established, profitable businesses, from New Orleans, Louisiana, USA (also West Palm Beach, FL). It states a focus on healthcare & life sciences, consumer & retail, food & beverage and industrials & manufacturing.

Capital raised$345macross 3 SEC-filed vehicles
Most recent fund2023filing since 2016
HeadquartersNew Orleans, Louisiana, USA (also West Palm Beach, FL)
Stated cheque sizeRevenue $15M+ and EBITDA $3M+

Stated investment criteria

What LongueVue Capital says it buys

Read from LongueVue Capital’s own website in August 2026. This is what the firm says it buys, not what anyone has recorded it buying, and figures are shown in the currency the firm itself used - nothing here is converted. Every line links to the page it was read from.

Minimum revenue it states$15m1
Minimum EBITDA it states$3m1
Transaction typesAdd-on, Recapitalisation2
Founded20014
OfficesHauppauge, New Orleans4
People listed on its team page103

A stated mandate is a firm’s description of itself and was true of the page on the day it was read; firms widen and narrow what they will look at without updating the site. The team figure counts the people the firm shows on one team page, so it is a floor rather than a headcount: firms that split their team across tabs or load it in pages will read low. Nothing here is a commitment by LongueVue Capital to consider any particular business, and nothing on this page is represented as being for sale.

SEC filings

What LongueVue Capital has raised

From this firm's own Form D filings. A fund files one within fifteen days of its first sale, under penalty of perjury, which makes these the hardest numbers on the page.

Vehicles filed3
Total capital raised$345m
Largest single vehicle$155m
Filing history2016 to 2023
Smallest accepted commitment$250k
Filed fromLOUISIANA

Form D covers US-domiciled vehicles raised from accredited investors. It will not capture a fund raised outside the United States, separately managed accounts, or capital deployed off balance sheet, so treat these as a floor rather than a total.

Recorded transactions

Buying and selling

Deals in which LongueVue Capital is named as buyer or seller in the transaction archive. 1 recorded exit, most recently in 2023.

CompanySideCounterpartyYearConsideration
Professional Rental ToolsSoldExpro2023$62m

Compiled from a transaction archive of 10,204 recorded deals. Most private transactions are never disclosed, so this is a sample of a firm’s activity rather than a complete record of it.

Valuation context

Transaction values in Healthcare & Life Sciences

What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.

Median consideration$110m
Middle 50%$30m-$318m
Revenue multiple2.8×
EBITDA multiple12.5×

The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.

For owners

Own a healthcare & life sciences business?

The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.

Request a confidential valuation

For investors

Is this LongueVue Capital?

Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.

Claim or correct this profile

Targeted buyer search

Which hundred of these would actually buy your business?

A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.

See how it works

Comparable investors

Similar mandates

Other buyout pe investors active in healthcare & life sciences.